Published

Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances.

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Future medicinal chemistry
Date: 2019-02-01
Source: PubMed
DOI: 10.4155/fmc-2018-0447
PubMed: 30763121

Authors

James E Robertshaw TL Westwell AD

Watch author

Derived topics and classifications

psilocybin General Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Defining 'psychedelic'.Journal of psychopharmacology (Oxford, England) · 2026-08-17 Psychedelic Therapy for DepressionUnknown journal · 2026-08-11 'So many relationships in the room': Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy.Psychology and psychotherapy · 2026-08-10 Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. AdultsAmerican Journal of Preventive Medicine · 2026-10-01 Single-crystal structure determination of psilocybin after dehydrationActa Crystallographica Section C Structural Chemistry · 2026-09-01 The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14 TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance TherapyClinicalTrials.gov · 2026-08-12 TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer SurvivorsClinicalTrials.gov · 2026-08-12